JY
ORIAU

Jeff Yass’s Orion Biotech Opportunities Corp. Units ORIAU Stock Holding History

Jeff Yass’s Portfolio ORIAU Stock Details ORIAU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,288
Closed -$101K – 14259
2022
Q3 		$101K Buy
+10,288
New +$101K ﹤0.01% 11701

Other funds holding ORIAU

JP
JNE Partners London, United Kingdom $243M AUM 2.37% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
GAM
Gritstone Asset Management Bethesda, Maryland $104M AUM 6.03% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jeff Yass's ORIAU Position: Q4 2022 in Review

Jeff Yass sold out of Orion Biotech Opportunities Corp. Units (ORIAU) in Q4 2022, closing a stake of 10,288 shares — an estimated $101K sold.

Jeff Yass first reported a position in ORIAU in Q3 2022 and held it in 1 quarter. The position peaked at $101K in Q3 2022. 6 funds tracked by Wall St. Rank hold ORIAU as of Q4 2022.

  • Jeff Yass reported no remaining Orion Biotech Opportunities Corp. Units position as of Q4 2022 after selling out during the quarter.
  • Jeff Yass sold 10,288 Orion Biotech Opportunities Corp. Units shares in Q4 2022, an estimated $101K.
  • Jeff Yass first reported a position in Orion Biotech Opportunities Corp. Units in Q3 2022 and held it in 1 quarter.
  • Jeff Yass's Orion Biotech Opportunities Corp. Units position peaked at $101K in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Units as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.